Condition
Attention-Deficit Hyperactivity Disorder(ADHD) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Attention-Deficit Hyperactivity Disorder(ADHD) clinical trials that are recruiting, in Japan. By phase: Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Long-term EB-1020 treatment for children with ADHD
This trial will test whether giving children with ADHD mainly high doses of EB-1020 for 52 weeks is safe.
-
EB-1020 (centanafadine) for ADHD in children and adolescents
This study tests two once-daily doses of EB-1020 (centanafadine) against placebo to see if it reduces ADHD symptoms and is safe for children and adolescents.
Quick answers
How many Attention-Deficit Hyperactivity Disorder(ADHD) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Japan. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.